USFDA issues 5 observations for Lupin Nagpur facility Ruchika Sharma31 Oct 2022 11:32 AM ISTMumbai: Lupin has recently announced that the US Food and Drug Administration has concluded a Pre-Approval Inspection (PAI) with five observations at...
BALATON, COMINO phase III studies of Vabysmo for people with retinal vein occlusion meet primary endpoints: Roche Ruchika Sharma30 Oct 2022 4:30 PM ISTBasel: Roche has announced positive topline results from two global phase III studies, BALATON and COMINO, evaluating the first and only bispecific...
CanSino Biologics inhalable COVID vaccine introduced in China Ruchika Sharma30 Oct 2022 1:30 PM ISTShanghai: In what is believed to be a world first, China's commerical capital of Shanghai this week introduced a new type of COVID-19 vaccine that is...
Italian tax authorities investigate Pfizer profits Ruchika Sharma30 Oct 2022 12:15 PM ISTMilan: Italy's tax authorities are investigating profits reported by Pfizer Inc's local unit Pfizer Italia srl, two sources with knowledge of the...
ViiV Healthcare Cabotegravir long-acting injectable for HIV prevention gets EMA validation Ruchika Sharma30 Oct 2022 11:45 AM ISTCabotegravir long-acting for PrEP is an integrase strand transfer inhibitor (INSTI).
Sanofi forecasts faster profit growth on Dupixent, flu vaccine demand Ruchika Sharma30 Oct 2022 10:00 AM ISTParis: French drugmaker Sanofi on Friday forecasted faster earnings growth this year on strong demand for its bestselling drug Dupixent and for...
CDSCO panel approves Intas pharma to continue Tofacitinib Ointment 2% CT Study Dr. Divya Colin29 Oct 2022 5:15 PM ISTNew Delhi: Citing that drug maker, Intas Pharma should report in case of any Serious Adverse Events (SAEs) related to the Phase III clinical trial of...
Laurus Labs gets 1 USFDA observation for Visakhapatnam facility Ruchika Sharma29 Oct 2022 3:32 PM ISTHyderabad: Laurus Labs today announced that the US Food and Drug Administration (USFDA) has concluded a PreApproval Inspection (PAI) with...
Merck lifts full-year forecast as cancer immunotherapy Keytruda sales soar Ruchika Sharma29 Oct 2022 1:30 PM ISTMerck has been looking to pursue deals to protect itself from an eventual revenue loss as Keytruda patents begin to expire toward the end of the...
Zydus Lifesciences bags USFDA nod for Pain relief injection Acetaminophen Ruchika Sharma29 Oct 2022 12:15 PM ISTIt is also used in combination with opioid (narcotic) medications to relieve moderate to severe pain.
Janssen TECVAYLI gets USFDA nod for relapsed or refractory multiple myeloma Ruchika Sharma29 Oct 2022 10:00 AM ISTTECVAYLI is a first-in-class, bispecific T-cell engager antibody that is administered as a subcutaneous treatment.
Medtronic to spin off patient monitoring, respiratory interventions businesses Ruchika Sharma28 Oct 2022 3:30 PM ISTThe separation, expected to be completed in the next 12 to 18 months, will also help the company unlock value from the two divested businesses.
